XENE (Xenon Pharmaceuticals Inc.) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold XENE (Xenon Pharmaceuticals Inc.) with a combined value of $310.10M across 6,918,805 shares. The largest holder is BlackRock, Inc. with a position worth $228.59M (0.00% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$310.10M
Total Shares Held
6,918,805
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $228.59M | 0.00% | +6.9% |
| 2 | CITADEL ADVISORS LLC | $64.08M | 0.01% | +41.5% |
| 3 | BAKER BROS. ADVISORS LP | $16.59M | 0.10% | - |
| 4 | Point72 Asset Management, L.P. | $833.65K | 0.00% | +0.0% |